- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04881084
Exploring Empathy and Compassion Using Digital Narratives
Learning to Care: Exploring Empathy and Compassion Using Digital Narratives
Study Overview
Status
Intervention / Treatment
Detailed Description
Digital stories -- first person, self-made 2-3-minute videos -- aim to generate awareness about problems, impart knowledge, or promote compassion. Sharing critical life events and related insights are invaluable for tellers and listeners alike, supporting catharsis, healing, reconciliation, and connectiveness. Digital stories are created and shared among organizations or citizens ( "ordinary" people without a background in filmmaking) to promote awareness of particular problems. They impact peoples' knowledge of contemporary issues, shaping attitudes by stimulating empathy, compassion, and active citizenship.
The proposed study explores digital stories/narratives, particularly those focused on mental health recovery, and how stories elicit empathy and compassion by addressing three main questions: (1) How is mental and emotional suffering depicted in video testimonies presented by social marketing/fundraising campaigns, versus the stories of ordinary people told through digital videos? (2) What impact does digital storytelling have for the creators, as ordinary people willing to revisit difficult life moments and transform them into digital videos? (3) What is the impact of video depictions on viewers in terms of empathy and compassion?
This mixed-method study has 3 phases: In Phase 1 (Preparation), a search will be conducted to identify activities related to Canadian social marketing and fundraising campaigns. Digital storytelling workshops will be held simultaneously, and in-depth interviews conducted before and after each workshop. Social service and community organizations located in Montreal, Canada, will be contacted to promote the digital storytelling workshops, to be implemented in the community and on university campuses. In Phase 2, a pilot randomized controlled trial (RCT) will be undertaken and more in-depth interviews conducted. Phase 3 will consist of knowledge dissemination activities.
The knowledge acquired through this study on individual and societal responses to stories of human suffering will have a practical impact on future social marketing campaigns promoted by government agencies, fundraising campaigns launched by nonprofit and for-profit organizations, and the public. Results will consolidate previous knowledge while providing new insights into what prompts citizens to help others.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Manuela Ferrari, PhD
- Phone Number: 4169270075
- Email: manuela.ferrari@mcgill.ca
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H4H 1R3
- Recruiting
- McGill University
-
Contact:
- Manuela Ferrari, PhD
- Phone Number: 4169270075
- Email: manuela.ferrari@mcgill.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-35 years of age
- Not currently admitted to a hospital
Exclusion Criteria:
- Not in age range (18-35 years of age)
- Currently admitted to a hospital
- Attended the digital storytelling workshop and made a digital story used in the RCT
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital storytelling group (Group 1)
Participants will be randomly assigned to the digital storytelling group (n = 40 participants; 20 Anglophone and 20 Francophone; ages 18-35).
Participants will be asked to watch twenty-six digital storytelling videos which will be assessed using a between-subjects design.
|
Participants (intervention- group 1) will watch digital stories, short videos describing the experience of recovering from mental illness created as part of this project.
Participants in the control group (group 2) will watch social marketing and/or fundraising campaigns on similar topics and complete a few questionnaires.
The following standardized scales will be used: The Level of Familiarity Scale (LOF) (which will be used only before exposure to movies); Toronto Empathy Questionnaire (16 items; internal consistency coefficient .79;
test-retest reliability coefficient .73),
Compassionate Love Scale (21 items; Cronbach's alpha: .95;
item-to-total correlations ranging from .46 to .81),
Dispositional Positive Emotions Scale (DPES) (5 items; Cronbach's alpha for the compassion subscale: .80;
inter-scale correlations: .44),
Self-Stigma of Mental Illness Scale-Short Form (SSMIS-SF) (20 items; Cronbach's alpha: 0.91); Difference and Disdain Scales for Public Stigma (DDSPS) (9 items).
|
|
Active Comparator: Social marketing/fundraising group (Group 2)
Participants will be randomly assigned to the social marketing/fundraising group (n = 40 participants; 20 Anglophone and 20 Francophone; ages 18-35).
Participants will be asked to watch twenty-six social marketing/fundraising videos which will be assessed using a between-subjects design.
|
Participants will be randomly assigned to the social marketing/fundraising group (n = 40 participants; 20 Anglophone and 20 Francophone; ages 18-35).
Participants will be asked to watch twenty-six social marketing/fundraising videos which will be assessed using a between-subjects design.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Empathy
Time Frame: Baseline, immediately after the intervention
|
Change in empathy using the Toronto Empathy Questionnaire.
The minimum scoring value is 0 and the maximum scoring value is 64.
A higher score means a better outcome.
|
Baseline, immediately after the intervention
|
|
Compassion
Time Frame: Baseline, immediately after the intervention
|
Change in compassion using the Compassionate Love Scale.
The minimum scoring value is 1 and the maximum scoring value is 7, which comes from the average of all item scores.
A higher score means a better outcome.
|
Baseline, immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive emotions
Time Frame: Baseline, immediately after the intervention
|
Change in positive emotions using the Dispositional Positive Emotions Scale.
The minimum scoring value is 5 and the maximum scoring value is 35.
A higher score means a better outcome.
|
Baseline, immediately after the intervention
|
|
Mental health self-stigma
Time Frame: Baseline, immediately after the intervention
|
Change in mental health stigma using the Self-Stigma of Mental Illness Scale-Short Form.
The minimum scoring value is 20 and the maximum scoring value is 180.
A higher score means a worse outcome.
|
Baseline, immediately after the intervention
|
|
Mental health public stigma
Time Frame: Baseline, immediately after the intervention
|
Change in mental health stigma using the Difference and Disdain Scales for Public Stigma.
The minimum scoring value is 9 and the maximum scoring value is 81.
A higher score means a worse outcome.
|
Baseline, immediately after the intervention
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 254043
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Compassion
-
University of CoimbraFundação para a Ciência e a TecnologiaActive, not recruiting
-
Kırıkkale UniversityNot yet recruiting
-
Fundación Saldarriaga ConchaPontificia Universidad Javeriana; Ministerio de Ciencia, Tecnología e InnovaciónNot yet recruitingResilience, Compassion
-
Robert SimpsonRecruiting
-
University of Texas at AustinCompleted
-
Sakarya UniversityCompletedCompassion | Cultural SensitivityTurkey (Türkiye)
-
Farah WiitaCompleted
-
Firat UniversityCompletedSelf-Compassion TrainingTurkey
-
Hospital Israelita Albert EinsteinCompletedAttention | Self-compassionBrazil
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingSelf-compassion Training (SCT) Plus Intranasal Oxytocin | Self-compassion Training (SCT) Plus Intranasal PlaceboSpain
Clinical Trials on Digital storytelling group
-
The Hong Kong Polytechnic UniversityHong Kong Children's Hospital; Research Grants Council, Hong KongRecruiting
-
Kocaeli UniversityGazi UniversityCompletedCancer | Child, Only | Symptoms and Signs | NarrationTurkey (Türkiye)
-
Mayo ClinicCompletedType2 DiabetesUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Hennepin... and other collaboratorsCompletedType2 DiabetesUnited States
-
Mayo ClinicHennepin Healthcare Research Institute; Mountain Park Health CenterCompleted
-
Arizona State UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHealth Knowledge, Attitudes, Practice | Human Papilloma Virus | Preventable Disease, Vaccine | NarrativeUnited States
-
Gazi UniversityCompletedNursing Students | Role Playing | Ethical Sensitivities | Analyses, Ethical | Digital Storytelling | Ethics Education | Ethical BehaviorTurkey
-
Arizona State UniversityNational Cancer Institute (NCI); Mayo ClinicCompletedDepression | Stress | Anxiety | Hematopoietic Stem Cell Transplantation | Bone Marrow Transplant | Information Disclosure | Psychosocial Health | NarrativeUnited States